Difference Between Interval and Continous Intradialytic Exercise on Functional Capacity in Hemodialysis Patient
Interval Versus Continous Intradialytic Training on Muscla Quality Index and Functional Capacity in Hemodialysis Patients
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this study is to find out the effect of interval versus continous intradialytic training on muscle quality index and functional capacity in Hemodialysis patients. The main question it aims to answer is: Does interval versus continous intradialytic training have an effect on muscle quality index and functional capacity in hemodialysis patients? Patients will be assigned randomly by computerized block randomization into two groups:Group (A): 30 patients will participate in 8 weeks of aerobic exercise in the form of high intensity interval training (HIIT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week).Group (B): 30 patients will participate in 8 weeks of aerobic exercise in the form of moderate intensity continous training (MICT) intradialytic pedaling exercise plus hemodialysis (3 sessions per week) . primary and secondary variables will be measured before starting treatment and after completion (after 2 months )
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2023
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 3, 2023
CompletedFirst Submitted
Initial submission to the registry
January 23, 2023
CompletedFirst Posted
Study publicly available on registry
February 10, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 10, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
September 10, 2023
CompletedSeptember 26, 2023
September 1, 2023
8 months
January 23, 2023
September 24, 2023
Conditions
Outcome Measures
Primary Outcomes (2)
muscle quality index
The MQI was quantified using a timed sit-to-stand test, body mass, and leg length to calculate a power index that is expressed in watts (W). The MQI was calculated as follows: QI (Watts) = ((Leg length×0.4) ×Bodymass×gravity×10) ∕ Time taken for (sit to stand 5 times) Body mass will be measured using a digital scale. Leg length will be taken using tape measure to measure the distance (in meters) from the greater trochanter of the femur to the lateral malleolus, measured from standing position . BY using a stopwatch, sit-to-stand time will be calculated as the time to stand from a seated position and return to sitting consecutively five times. The use of arms not allowed during the sit-to-stand test. Acceleration of gravity (9.8 m/s2). After measuring leg length, body mass and time for sit to stand, all these data will be written in the previous equation to calculate muscle quality index and expressed in watts (W).
2 months
six minute walk test
Six minute walk test (6MWT) to assess physical functional capacity (using stopwatch, colored tape to mark starting line and end line of corridor) Using a stopwatch, assess physical functional capability. The 6MWT will be conducted indoors along a 30 m long, level, straight, enclosed hallway, with the length of the corridor indicated with brightly coloured tape at the beginning and end lines. Subjects will be advised to walk as far as possible from end to end of the corridor without jogging or running, and to cover as much distance as feasible in the 6 minute time limit . This test was performed at the beginning of treatment and at the end of treatment program (8 weeks) to assess functional performance difference.
2 months
Study Arms (2)
High Intensity Interval Training Group (Group A)
EXPERIMENTALEach training session consist of three parts of 30 minutes: * Warm up (5 minutes) free active exercise of the lower extremities, * Training continued with three exercise intervals lasting 3 min each, at an exercise intensity of 85%-95% of HRpeak equalling 15-17 on the Borg scale. Each interval was separated by 4 min of active breaks at an intensity of 60%-70% of HRpeak. * Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.
Moderate intensity continous training group (Group B)
EXPERIMENTALEach training session consist of three parts of 30 minutes: * Warm up (5 minutes) free active exercise of the lower extremities, * Training continued with cycling at low-to-moderate exercise intensity of 50%-60% of HRpeak, representing 11-13 on the Borg scale. * Cool down (5 minutes) free exercise of lower extremities. Training program will last for 8 weeks with frequency 3times / week.
Interventions
aerobic exercise in the form of leg pedaling exercise in semi-supine position using leg ergometer by different intensities
Eligibility Criteria
You may qualify if:
- Age between 45- 55 years.
- Male sex included.
- Patients with grade 5 chronic renal failure on hemodialysis.
- Patients are on hemodialysis for 1-3 years.
- Body mass index (BMI) range from 25-34.9 Kg/m2.
- They will be medically and psychologically stable.
- Receiving their physician-prescribed pharmacotherapy regularly.
- Agree to participate by signing an informed consent form.
You may not qualify if:
- Inability to comprehend and follow instructions as in dementia or speech problems such as dysphasia.
- Patients with unstable angina, uncontrolled cardiac arrhythmia, decompensated heart failure, persistent systolic blood pressure (BP) greater than 200 mmHg, persistent diastolic BP greater than 120 mmHg, acute pericarditis or myocarditis.
- Acute systemic infection.
- Presence of malignant disease.
- Patients with Diabetes Mellitus.
- Patients with Lupus Nephritis.
- Patients with chronic obstructive lung disease, restrictive lung disease or chronic chest infection.
- Severe obesity (BMI \> 35).
- Chronic inflammatory orthopedic disorders and rheumatoid arthritis.
- Patients with muscle injuries or neuromuscular disorders (muscular dystrophy, myasthenia gravis, myopathy, multiple sclerosis and peripheral neuropathy).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
Study Sites (1)
Faculty of physical therapy, cairo university
Cairo, Dokki, 12611, Egypt
Study Officials
- STUDY DIRECTOR
hala m ezz eldeen, professor
department of cardiovascular, respiratory and geriatrics disorders
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Masking Details
- block randomization and envelopes
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assistant lecturer at department of cardiovascular, respiratory and geriatrics
Study Record Dates
First Submitted
January 23, 2023
First Posted
February 10, 2023
Study Start
January 3, 2023
Primary Completion
September 10, 2023
Study Completion
September 10, 2023
Last Updated
September 26, 2023
Record last verified: 2023-09
Data Sharing
- IPD Sharing
- Will not share
after completion of the study and publication, data will be available for other researchers